CME/CE

Accreditation Statements

Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Nurses
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation Statements

Physicians
eNewsletter: The Johns Hopkins University School of Medicine designates this enduring material – internet activity for a maximum of 7 AMA PRA Category 1 Credits™ (1 AMA PRA Category 1 Credit™ per monthly review). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Podcast: The Johns Hopkins University School of Medicine designates this enduring material – internet activity for a maximum of 3 AMA PRA Category 1 Credits™.

Nurses
eNewsletter: This 1 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 1 contact hour, or a total of 7 contact hours for the 7 newsletters in this program.

Podcast: These paired 0.5 contact hour Educational Activities are provided by the Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact hour, or a total of 3 contact hours for the 6 podcasts in this program.

Course Format

The eCysticFibrosis Review series consists of a monthly review of journal literature on key, pertinent topics, emailed as either a newsletter or podcast, to clinicians caring for patients with cystic fibrosis. The timely commentary on current research, best practices and clinical management issues is provided by an expert panel of cystic fibrosis specialists. The activities are delivered as 7 bi-monthly newsletters and 6 alternating podcasts. Participants will have up to 2 years to complete the 7 newsletters and 6 podcasts in order to earn CME credit.

Date of release: September 28, 2018
Expiration date: September 27, 2021

Estimated time to complete each activity: 60 minutes per newsletter, 30 minutes per podcast.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

  • Discuss data showing the value of switching agents to effectively treat chronic Pseudomonas aeruginosa in patients with cystic fibrosis.
  • Analyze data and expert opinion on how to design antibiotic regimens in patients with chronic Pseudomonas aeruginosa, using a cycled approach to treatment.
  • Translate real-world and long-term data on the use of modulators in clinical practice in order to provide optimal patient care.
  • Identify new and emerging disease modifying therapies and discuss their role in the CFTR treatment armamentarium.
  • Explain the effects of modulators on patients’ nutritional status, and how this impacts pancreatic enzyme replacement therapy (PERT).
  • Identify patient populations who should be screened for colorectal cancer and how new guidelines should be implemented into practice.

Statement of Responsibility

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Statement of Need

  • Clinicians may not be aware of currently available data on the value of switching agents in patients with cystic fibrosis undergoing treatment for chronic Pseudomonas aeruginosa.
  • Clinicians may not be able design effective long-term inhaled antibiotic therapy regimens for patients chronically infected with Pseudomonas aeruginosa.
  • Clinicians may not be aware of real-world and long-term data regarding use of disease-modifying therapies, which could offer insights for better care of their patients with cystic fibrosis.
  • Clinicians are not aware of the latest trial results for recently approved and promising disease-modifying treatments currently in late-stage development.
  • Clinicians may not be properly managing their patients’ nutritional status because they are not familiar with how modulators could impact the use of pancreatic enzymes.
  • Clinicians may not be aware of the recently introduced recommendations for screening for colorectal cancer among adults with CF, jeopardizing improved opportunity to prevent, detect, and cure colon cancer while in early stages.

Volume 8 supported by educational grants from AbbVie, Inc., Chiesi USA, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated.

Successful Completion

To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) complete the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section. Physicians must attest to the amount of time they spent on the activity.

A passing grade of 70% or higher on the post-test/evaluation is required to receive CME credit.

Intended Audience

The target audience (clinicians) for this initiative includes pulmonologists, pediatric pulmonologists, gastroenterologists, pediatricians, infectious disease specialists, respiratory therapists, dieticians, nutritionists, nurses, and physical therapists.

There are no fees or prerequisites for this activity.

Full Disclosure Policy Affecting CME Activities

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:

Dr. Noah Lechtzin has reported that he has served as consultant for Cytokinetics, Hill-Rom, and Vertex Pharmaceuticals Incorporated.

Dr. Peter Mogayzel has reported that he has served as a co-investigator for Gilead Sciences, Inc. and a principal investigator for Vertex Pharmaceuticals Incorporated.

Suzanne Sullivan discloses that she has no financial relationships with commercial supporters.

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Disclosure Policy

It is the policy of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

Privacy Policy

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.

To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit www.hopkinscme.cloud-cme.com

Disclaimer Statement

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

Confidentiality Disclaimer for CME Activity Participants

I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the Privacy Regulations). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos on any social medial site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.

"The Office of Continuing Medical Education at The Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."

For CME questions, please contact the CME Office (410) 955-2959 or e-mail cmenet@jhmi.edu. For certificates, please call (410) 502-9636.

Johns Hopkins University School of Medicine Office of Continuing Medical Education
Turner 20/720 Rutland Avenue
Baltimore, Maryland 21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)

Hardware & Software Requirements

To access activities, users will need:

  • A computer with an internet connection
  • An HTML5 compliant web browser or Internet Explorer 8 (and higher)

Copyright © JHUSOM and eCysticFibrosis Review | Presented by JHUSOM in collaboration with DKBmed.